Sapphire Lifesciences Private Limited

Sapphire Lifesciences Private Limited - pharma in Palghar, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH1990PTC055572 Incorporated 26 February 1990 ROC Mumbai HQ Palghar, Maharashtra, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹56.47 Cr
▼ 47% YoY
Net loss · FY 2025
₹8.29 Cr
Net margin -14.7%
EBITDA · FY 2025
-₹7.89 Cr
EBITDA margin -14%
Authorised capital
₹13.5 Cr
Registered with MCA
Paid-up capital
₹13.34 Cr
Issued & subscribed
Open charges
₹15.76 Cr
Satisfied ₹7.22 Cr
Company age
36 yrs
Est. 1990
Directors on board
2
As per MCA filings

About Sapphire Lifesciences Private Limited

Data last updated:

Sapphire Lifesciences Private Limited is a private limited company based in Palghar, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 February 1990 and has been in existence for over 36 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1990PTC055572. Its GSTIN is 27AAACS5856R1ZJ (Maharashtra).

The company has an authorised share capital of ₹13.5 Cr and a paid-up capital of ₹13.34 Cr. It was formerly known as Saphire Lifesciences Private Limited and Saphire Capules Private Limited. It is led by directors Parag Kishor Shah and Ganesh Shenoy Baburaya.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 44 & 45 Palghar Taluka Ind. Co – Op Estate Ltd. Boisar Road Palghar, Maharashtra, India – 401404.

As per the financials filed for FY 2025, the company reported a revenue of ₹56.47 Cr, a decline of 47% compared to the previous year. For the same year it recorded a net loss of ₹8.29 Cr (net margin -14.7%) and EBITDA of -₹7.89 Cr (EBITDA margin -14%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 1% over five years.

As per MCA filings, the company has open charges of ₹15.76 Cr and satisfied charges of ₹7.22 Cr on record. Court records list 74 cases involving the company, including 2 filed by the company and 72 filed against it; 1 case is pending.

Sapphire Lifesciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0001883). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239MH1990PTC055572
Registration Number 055572
Incorporation Date 26 February 1990
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-17-0001883

Name history

Sapphire Lifesciences has undergone 3 name changes throughout its history. The company was previously known as Saphire Lifesciences Private Limited, Saphire Capules Private Limited, and Saphire Lifesciences Pvt.Ltd. The current legal name is Sapphire Lifesciences Private Limited.

Company NameStatus
Sapphire Lifesciences Private LimitedCurrent
Saphire Lifesciences Private LimitedPrevious
Saphire Capules Private LimitedPrevious
Saphire Lifesciences Pvt.LtdPrevious
Key People
Parag Kishor Shah Director Ganesh Shenoy Baburaya Director

Recognitions & Rankings of Sapphire Lifesciences

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-17-0001883

Contact details

Sapphire Lifesciences Private Limited's registered office is in Palghar, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No. 44 & 45 Palghar Taluka Ind. Co – Op Estate Ltd. Boisar Road Palghar, Maharashtra, India – 401404
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Sapphire Lifesciences Private Limited, buy the company report.

Comprehensive company report
Sapphire Lifesciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Sapphire Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Sapphire Lifesciences Private Limited, buy the company report.

Financials of Sapphire Lifesciences Private Limited

FY 2025 filings available

Sapphire Lifesciences Private Limited reported revenue of ₹56.47 Cr (down 47% YoY) for FY 2025.

Revenue · FY 2025
₹56.47 Cr ▼ 47%
Net loss · FY 2025
₹8.29 Cr margin -14.7%
EBITDA · FY 2025
-₹7.89 Cr margin -14%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 47%
3 years · compounded
▼ 27%
5 years · compounded
▲ 1%

Revenue fell 47% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations₹56.47 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹7.89 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹8.29 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-14%
Net Profit Margin-14.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sapphire Lifesciences Private Limited, buy the company report.

Board of directors of Sapphire Lifesciences Private Limited

Sapphire Lifesciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Parag Kishor ShahDirector30 Mar 200422 Years 7 MonthsCurrent
Ganesh Shenoy BaburayaDirector27 Nov 20187 Years 11 MonthsCurrent
View all directors

Peer comparison

Sapphire Lifesciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Micropure Parenterals Private Limited₹56.66 Cr (FY 2025)37.0%Mumbai, Maharashtra, India
Biochemix Healthcare Private Limited₹56.61 Cr (FY 2024)9.0%Yamuna Nagar, Haryana, India
Sapphire Lifesciences Private Limitedthis company₹56.47 Cr (FY 2025)-₹8.29 Cr-14.7%-47.0%Palghar, Maharashtra, India
Nandani Medical Laboratories Pvt Ltd₹55.89 Cr (FY 2024)37.0%Indore, Madhya Pradesh, India

To see the full peer comparison of Sapphire Lifesciences Private Limited, buy the company report.

Shareholding

The shareholding of Sapphire Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sapphire Lifesciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹15.76 Cr
Satisfied charges
₹7.22 Cr
Breakdown by lending institutions
Others₹15.76 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
03 May 2017100097467Others₹3 CrOpen
28 Feb 201310410241Others₹12.76 CrOpen
03 Sep 2020100385849Others₹81.85 LakhSatisfied
26 May 2020100338769Others₹1.25 CrSatisfied
30 Dec 201510615519Central Bank of India₹1.5 CrSatisfied

To see the full charge records of Sapphire Lifesciences Private Limited, buy the company report.

Total charge records: 8 View all charges

Credit ratings & regulatory alerts

Sapphire Lifesciences Private Limited was last rated by Icra on 15 Mar 2022.

Rating agencyRated onRating
Icra15 Mar 2022

To see the full credit ratings and regulatory alerts of Sapphire Lifesciences Private Limited, buy the company report.

MSME payment delays

Sapphire Lifesciences Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (2 of 2)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier

To see the full MSME payment records of Sapphire Lifesciences Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Sapphire Lifesciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACS5856R1ZJMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Sapphire Lifesciences Private Limited, buy the company report.

Recent activity

Sapphire Lifesciences Private Limited has 4 board changes on record since 2004: 2 appointments and 2 cessations. The latest: Agnello Edward Fernandez ceased to be Director on 01 Oct 2022.

Charges
A charge with Others of Rs. 12.76 Cr registered on 28 Feb 2013 with Charge ID 10410241 was modified on 30 Jul 2025.
Filing
Sapphire Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
AGM
Sapphire Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 26 May 2020 via Charge ID 100338769 with Others was fully satisfied on 30 Mar 2023.
Ceased
Agnello Edward Fernandez ceased to be Director.
Charges
A charge registered on 03 Sep 2020 via Charge ID 100385849 with Others was fully satisfied on 24 Mar 2021.
Charges
A charge with Others amounted to Rs. 0.82 Cr with Charge ID 100385849 was registered on 03 Sep 2020.
Charges
A charge with Others amounted to Rs. 1.25 Cr with Charge ID 100338769 was registered on 26 May 2020.
Appointed
Ganesh Shenoy Baburaya was appointed as Director.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100097467 was registered on 03 May 2017.
Charges
A charge registered on 30 Dec 2015 via Charge ID 10615519 with Central Bank Of India was fully satisfied on 16 Mar 2016.
Charges
A charge with Central Bank Of India amounted to Rs. 1.50 Cr with Charge ID 10615519 was registered on 30 Dec 2015.

11 earlier events are in the company report.

Frequently asked questions

Sapphire Lifesciences is an active private limited company based in Palghar, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 February 1990 (36+ years old) and is registered under CIN U24239MH1990PTC055572.

Sapphire Lifesciences has 2 current directors:

The latest financial statements of Sapphire Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Sapphire Lifesciences is 27AAACS5856R1ZJ, registered in Maharashtra.

The CIN (Corporate Identification Number) of Sapphire Lifesciences is U24239MH1990PTC055572. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sapphire Lifesciences has 74 court cases on record: 2 filed by the company and 72 filed against it. 1 is pending. Most are in the district courts.

Sapphire Lifesciences was incorporated on 26 February 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Sapphire Lifesciences by revenue are Micropure Parenterals Private Limited, Biochemix Healthcare Private Limited, Nandani Medical Laboratories Pvt Ltd, all in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Agnello Edward Fernandez ceased to be Director on 01 Oct 2022. Ganesh Shenoy Baburaya was appointed as Director on 27 Nov 2018. Ganesh Shenoy Baburaya ceased to be Director on 31 Mar 2004. Sapphire Lifesciences has 4 board changes on record in total.

Yes, Sapphire Lifesciences is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-17-0001883).

Sapphire Lifesciences has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. The latest return was filed on 30 May 2019.

The registered office of Sapphire Lifesciences is at Plot No. 44 & 45 Palghar Taluka Ind. Co – Op Estate Ltd. Boisar Road Palghar, Maharashtra, India – 401404.